Tocotrienols unable to reduce chronic pain, but may minimise ‘stabbing’ pain in diabetics

Tocotrienols unable to reduce chronic pain, but may minimise ‘stabbing’ pain in diabetics

Diabetic peripheral neuropathy (DPN) is nerve damage induced by diabetes and chronically high blood sugar, and affects 26% to 53% of diabetes patients worldwide; 21% to 53% of DPN sufferers experience ongoing neuropathic pain, which decreases their quality of life and has been reported to cost them 4.2 times more in medical expenditure than for those without neuropathic pain.

Tocotrienols, which are different forms of vitamin E, have been known to modulate the neuropathic pathway and are therefore thought to be able to alleviate neuropathic symptoms via their anti-inflammatory and anti-oxidative properties.

tocotrienol-stabbing-pain

Source: NUTRAingredients-asia.com. Read more here.